Skip to main content

Table 1 Characteristics of LRRK2 substitutions associated with parkinsonism

From: The role of the LRRK2 gene in Parkinsonism

Amino-acid variation

Position

Protein domain

Main phenotype

Risk ethnicty

Neuropathology

Ref

R1441C

Exon31

ROCc

PD

Middle European

Lewy bodies

[22]

SN neuronal loss

Neurofibrillary tangles

Ubiquitin staining

R1441G

Exon31

ROCc

PD

Caucasian (Basque Country) Italy

SN neuronal loss

[28]

Ubiquitin staining

R1441H

Exon31

ROCc

PD

NAb

Unknown

[23]

R1628P

Exon 34

CORc

PD

Chinese

Unknown

[24]

Y1699C

Exon 35

CORc

PD

NAb

Lewy bodies

[25]

SN neuronal loss

Neurofibrillary tangles(Stage IIa)

Ubiquitin staining

G2019S

Exon 41

Kinase

PD

In virtually all the populations especially North African

Lewy bodies

[30, 32, 43]

SN neuronal loss

Neurofibrillary tangles (Stage Va)

Ubiquitin staining

I2020T

Exon 41

Kinase

PD

NAb

Lewy bodies

[29]

SN neuronal loss

R2385R

Exon 48

WD40

PD

East Asian

Unknown

[13]

  1. aStage refers to the highest reported Braak stage.
  2. bNA, Not applicable.
  3. cRoc: Ras of complex (GTPase). COR: C-terminal of Ras.